mapping the effectiveness and risks of glp-1 receptor agonists Mapping the effectiveness and risks

The result: reduced risk for depression and improved mental health

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

Pull off the inner needle shield and throw it away

Compounded tirzepatide ranges from $150 to $500 per month

The delayed gastric emptying caused by GLP-1 medications can affect the absorption of oral medications, particularly those requiring rapid absorption or those with narrow therapeutic windows

(2024) Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trials